journal article·2024-06-19

Molecular Basis for Surface-Initiated Non-Thrombin-Generated Clot Formation Following Viral Infection

Kao Li, Kuan-Che Feng, Marcia Simon, Yuyang Fu, Dennis Galanakis, Steffen Mueller, Miriam H. Rafailovich

ACS Applied Materials & Interfaces· Volume 16· Issue 24
Publisher page

Abstract

In this paper, we propose a model that connects two standard inflammatory responses to viral infection, namely, elevation of fibrinogen and the lipid drop shower, to the initiation of non-thrombin-generated clot formation. In order to understand the molecular basis for the formation of non-thrombin-generated clots following viral infection, human epithelial and Madin-Darby Canine Kidney (MDCK, epithelial) cells were infected with H1N1, OC43, and adenovirus, and conditioned media was collected, which was later used to treat human umbilical vein endothelial cells and human lung microvascular endothelial cells. After direct infection or after exposure to conditioned media from infected cells, tissue surfaces of both epithelial and endothelial cells, exposed to 8 mg/mL fibrinogen, were observed to initiate fibrillogenesis in the absence of thrombin. No fibers were observed after direct viral exposure of the endothelium or when the epithelium cells were exposed to SARS-CoV-2 isolated spike proteins. Heating the conditioned media to 60 °C had no effect on fibrillogenesis, indicating that the effect was not enzymatic but rather associated with relatively thermally stable inflammatory factors released soon after viral infection. Spontaneous fibrillogenesis had previously been reported and interpreted as being due to the release of the alpha C domains due to strong interactions of the interior of the fibrinogen molecule in contact with hydrophobic material surfaces rather than cleavage of the fibrinopeptides. Contact angle goniometry and immunohistochemistry were used to demonstrate that the lipids produced within the epithelium and released in the conditioned media, probably after the death of infected epithelial cells, formed a hydrophobic residue responsible for fibrillogenesis. Hence, the standard inflammatory response constitutes the ideal conditions for surface-initiated clot formation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Blood properties and coagulation · Platelet Disorders and Treatments · Blood Coagulation and Thrombosis Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedicine and Nursing, Shandong Institute of Petroleum and Chemical Technology, Dongying 257061, Shandong, China

Department of Materials Science and Chemical Engineering, Stony Brook University, Stony Brook, New York 11794, United States

Department of Oral Biology and Pathology, Stony Brook University Medical Center, Stony Brook, New York 11794, United States

Dongying Stem Cell Bank Medical Technology Co., Ltd., Dongying 257000, Shandong, China

Department of Pathology, Stony Brook University School of Medicine, Stony Brook, New York 11720, United States

Codagenix Inc., Farmingdale, New York 11735, United States

Funding

National Science Foundation · Louis Morin Charitable Trust

References (53)

Show source-provided references
1. 10.1056/NEJMoa201543210.1056/NEJMoa2015432 ↗
2. 10.1016/j.eclinm.2020.10063910.1016/j.eclinm.2020.100639 ↗
3. Price L. C. · 2020
4. 10.1001/jama.2009.153610.1001/jama.2009.1536 ↗
5. 10.1016/j.ejim.2015.08.01710.1016/j.ejim.2015.08.017 ↗
6. Madjid M. · Tex. Heart Inst. J. · 2004 · 31 · 4
7. 10.1371/journal.ppat.100322910.1371/journal.ppat.1003229 ↗
8. 10.4161/viru.2577910.4161/viru.25779 ↗
9. 10.1016/s2213-2600(20)30216-210.1016/s2213-2600(20)30216-2 ↗
10. 10.1007/s12185-020-03029-y10.1007/s12185-020-03029-y ↗
11. 10.1016/j.actbio.2017.03.00210.1016/j.actbio.2017.03.002 ↗
12. 10.1111/j.1538-7836.2010.04072.x10.1111/j.1538-7836.2010.04072.x ↗
13. 10.1038/s41467-021-24632-510.1038/s41467-021-24632-5 ↗
14. 10.1038/s41419-021-03527-910.1038/s41419-021-03527-9 ↗
15. 10.1128/mbio.03185-2010.1128/mbio.03185-20 ↗
16. 10.1093/cid/ciab40610.1093/cid/ciab406 ↗
17. 10.1128/jvi.00110-2110.1128/jvi.00110-21 ↗
18. 10.1038/cmi.2016.110.1038/cmi.2016.1 ↗
19. 10.3389/fmicb.2014.0065310.3389/fmicb.2014.00653 ↗
20. 10.1016/S0008-8749(03)00058-310.1016/S0008-8749(03)00058-3 ↗
21. 10.1038/s41419-020-03252-910.1038/s41419-020-03252-9 ↗
22. 10.1038/s41379-021-00808-810.1038/s41379-021-00808-8 ↗
23. 10.1111/jth.1485410.1111/jth.14854 ↗
24. 10.1111/jth.1485010.1111/jth.14850 ↗
25. 10.1111/jth.1476810.1111/jth.14768 ↗
26. 10.1007/978-3-319-49674-0_1310.1007/978-3-319-49674-0_13 ↗
27. 10.1161/01.ATV.18.12.194810.1161/01.ATV.18.12.1948 ↗
28. 10.1161/01.ATV.15.6.78610.1161/01.ATV.15.6.786 ↗
29. 10.1055/s-0041-172597610.1055/s-0041-1725976 ↗
30. 10.1021/la001778110.1021/la0017781 ↗
31. 10.1016/0049-3848(95)00063-W10.1016/0049-3848(95)00063-W ↗
32. 10.1183/13993003.01282-201510.1183/13993003.01282-2015 ↗
33. 10.1371/journal.ppat.100912810.1371/journal.ppat.1009128 ↗
34. 10.1093/femspd/fty08710.1093/femspd/fty087 ↗
35. 10.3390/v406101110.3390/v4061011 ↗
36. 10.1016/j.virol.2016.04.00810.1016/j.virol.2016.04.008 ↗
37. Lynch, J. P.; Fishbein, M.; Echavarria, M. Adenovirus; Thieme Medical Publishers, 2011; pp 494–511.10.1055/s-0031-1283287 ↗
38. 10.1038/s41392-020-00454-710.1038/s41392-020-00454-7 ↗
39. 10.1038/s41577-020-0343-010.1038/s41577-020-0343-0 ↗
40. 10.1016/S0140-6736(20)30937-510.1016/S0140-6736(20)30937-5 ↗
41. 10.3389/fimmu.2018.0158110.3389/fimmu.2018.01581 ↗
42. 10.1016/j.cell.2009.12.01810.1016/j.cell.2009.12.018 ↗
43. 10.3390/v1305074610.3390/v13050746 ↗
44. 10.1111/j.1365-2672.2012.05282.x10.1111/j.1365-2672.2012.05282.x ↗
45. 10.3390/molecules2521505310.3390/molecules25215053 ↗
46. 10.1111/j.1600-0854.2009.00994.x10.1111/j.1600-0854.2009.00994.x ↗
47. 10.1093/femsre/fuaa06610.1093/femsre/fuaa066 ↗
48. 10.1016/j.yexcr.2015.11.00810.1016/j.yexcr.2015.11.008 ↗
49. 10.1177/251525641989722610.1177/2515256419897226 ↗
50. 10.1126/science.aaw258610.1126/science.aaw2586 ↗
51. 10.1016/j.ceb.2012.05.01210.1016/j.ceb.2012.05.012 ↗
52. 10.1016/S1473-3099(13)70286-X10.1016/S1473-3099(13)70286-X ↗
53. 10.1073/pnas.080486510510.1073/pnas.0804865105 ↗